LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Enzastaurin | 0.04 | uM | LJP5 | 3 | D18 | 72 | hr | 2543 | 6141 | 5760 | 1.0660 | 1.1113 |
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 1 | D17 | 72 | hr | 2543 | 5838 | 5734 | 1.0180 | 1.0307 |
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 2 | D17 | 72 | hr | 2543 | 6050 | 5761 | 1.0501 | 1.0846 |
| SK-BR-3 | Enzastaurin | 0.12 | uM | LJP5 | 3 | D17 | 72 | hr | 2543 | 5884 | 5760 | 1.0214 | 1.0362 |
| SK-BR-3 | Enzastaurin | 0.37 | uM | LJP5 | 1 | D16 | 72 | hr | 2543 | 5962 | 5734 | 1.0397 | 1.0675 |
| SK-BR-3 | Enzastaurin | 0.37 | uM | LJP5 | 2 | D16 | 72 | hr | 2543 | 6004 | 5761 | 1.0421 | 1.0712 |
| SK-BR-3 | Enzastaurin | 0.37 | uM | LJP5 | 3 | D16 | 72 | hr | 2543 | 5915 | 5760 | 1.0268 | 1.0453 |
| SK-BR-3 | Enzastaurin | 1.11 | uM | LJP5 | 1 | D15 | 72 | hr | 2543 | 5787 | 5734 | 1.0092 | 1.0156 |
| SK-BR-3 | Enzastaurin | 1.11 | uM | LJP5 | 2 | D15 | 72 | hr | 2543 | 5864 | 5761 | 1.0178 | 1.0301 |
| SK-BR-3 | Enzastaurin | 1.11 | uM | LJP5 | 3 | D15 | 72 | hr | 2543 | 5943 | 5760 | 1.0316 | 1.0535 |
| SK-BR-3 | Enzastaurin | 3.33 | uM | LJP5 | 1 | D14 | 72 | hr | 2543 | 5546 | 5734 | 0.9671 | 0.9438 |
| SK-BR-3 | Enzastaurin | 3.33 | uM | LJP5 | 2 | D14 | 72 | hr | 2543 | 5901 | 5761 | 1.0242 | 1.0410 |
| SK-BR-3 | Enzastaurin | 3.33 | uM | LJP5 | 3 | D14 | 72 | hr | 2543 | 5902 | 5760 | 1.0245 | 1.0415 |
| SK-BR-3 | Enzastaurin | 10 | uM | LJP5 | 1 | D13 | 72 | hr | 2543 | 6021 | 5734 | 1.0500 | 1.0849 |
| SK-BR-3 | Enzastaurin | 10 | uM | LJP5 | 2 | D13 | 72 | hr | 2543 | 6321 | 5761 | 1.0971 | 1.1635 |
| SK-BR-3 | Enzastaurin | 10 | uM | LJP5 | 3 | D13 | 72 | hr | 2543 | 6171 | 5760 | 1.0712 | 1.1201 |
| SK-BR-3 | Palbociclib | 0.04 | uM | LJP6 | 1 | E18 | 72 | hr | 2543 | 4916 | 5258 | 0.9348 | 0.8754 |
| SK-BR-3 | Palbociclib | 0.04 | uM | LJP6 | 2 | E18 | 72 | hr | 2543 | 5024 | 5438 | 0.9238 | 0.8606 |
| SK-BR-3 | Palbociclib | 0.04 | uM | LJP6 | 3 | E18 | 72 | hr | 2543 | 4739 | 5557 | 0.8527 | 0.7365 |
| SK-BR-3 | Palbociclib | 0.12 | uM | LJP6 | 1 | E17 | 72 | hr | 2543 | 4531 | 5258 | 0.8616 | 0.7350 |
| SK-BR-3 | Palbociclib | 0.12 | uM | LJP6 | 2 | E17 | 72 | hr | 2543 | 4483 | 5438 | 0.8244 | 0.6769 |
| SK-BR-3 | Palbociclib | 0.12 | uM | LJP6 | 3 | E17 | 72 | hr | 2543 | 4384 | 5557 | 0.7889 | 0.6207 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 1 | E16 | 72 | hr | 2543 | 4423 | 5258 | 0.8411 | 0.6955 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 2 | E16 | 72 | hr | 2543 | 4135 | 5438 | 0.7604 | 0.5578 |
| SK-BR-3 | Palbociclib | 0.37 | uM | LJP6 | 3 | E16 | 72 | hr | 2543 | 4171 | 5557 | 0.7505 | 0.5506 |